Tag: liquidity

In this 2025 forecast update, Wealth Megatrends, in collaboration with Weiss Ratings, offers unique insights into gold's continued upward trajectory. The release outlines Sean Brodrick's updated projection of $6,900 gold, framed within rising central bank demand, ongoing monetary volatility, and long-term shifts in asset preservation behavior. This analysis offers a distinct perspective on how this cycle compares to prior periods of financial instability and why mining equities are again drawing interest as part of a broader conversation on gold's role in today's evolving macroeconomic environment.

In this 2025 strategic update, Safe Money Report outlines a six-step framework for navigating financial instability during what Martin Weiss calls the “Age of Chaos.” With decades of historical data behind its Weiss Ratings system, the firm presents a non-promotional roadmap for evaluating liquidity, asset safety, inflation hedges, and emerging market trends in crypto and real estate. The release examines current economic conditions and how informed analysis, rather than emotion, can inform long-term wealth protection strategies.

Half-year statement of the liquidity contract
As of June 30, 2025

Half-yearly report on the liquidity contract

Paris, July 3^rd, 2025

PANAMA CITY, July 03, 2025 (GLOBE NEWSWIRE) -- In July 2025, Gate, a global leading digital asset trading platform, officially launched its xStocks trading section, covering both spot and futures markets. The initial listings include 8 popular tokenized stocks, such as COINX, NVDAX, CRCLX, AAPLX, METAX, HOODX, TSLAX, and GOOGLX, enabling global users to trade tokenized stocks directly with crypto assets like USDT. Gate Alpha has also rolled out support for xStocks, listing MSTRx, CRCLx, SPYx, NVDAx, TSLAx, and AAPLx, further expanding users’ access to on-chain assets and strategic trading options.

CI/CD integration, a dedicated "test farm" and a focus on innovative efficiency and automation solutions reduced certification times from the expected 12-18 months to 8 months

MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products, whereby the Purchaser will acquire all the issued and outstanding common shares of the Company for US$3.01 per share in cash plus one contingent value right (“CVR”) per share for additional aggregate cash payments of up to US$1.19 per CVR if certain milestones as described below are achieved (the “Transaction”). The total Transaction consideration, assuming full payment of the CVRs, is US$254 million.